Kringle Pharma Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
19
- Stock Symbol
-
4884
- Share Price
-
$3.48
- (As of Friday Closing)
Kringle Pharma General Information
Description
Kringle Pharma Inc is engaged in the research and development of HGF (hepatocyte growth factor) protein as a therapeutic agent for intractable diseases. The Company operates in a single segment, pharmaceutical development.
Contact Information
Website
www.kringle-pharma.comCorporate Office
- 207 Saito Bio-Incubator
- 7-7-15 Saitoasagi, Ibaraki
- Osaka, 567-0085
- Japan
Corporate Office
- 207 Saito Bio-Incubator
- 7-7-15 Saitoasagi, Ibaraki
- Osaka, 567-0085
- Japan
Kringle Pharma Stock Performance
As of 13-Nov-2026, Kringle Pharma’s stock price is $3.48. Its current market cap is $28.1M with 8.08M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.48 | $3.25 | $1.79 - $4.67 | $28.1M | 8.08M | 281K | -$0.71 |
Kringle Pharma Financials Summary
As of 30-Jun-2026, Kringle Pharma has a trailing 12-month revenue of $2.22M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 30-Sep-2025 | FY 2024 30-Sep-2024 | FY 2023 30-Sep-2023 |
|---|---|---|---|---|
| EV | 6,704 | 10,275 | 23,136 | 12,960 |
| Revenue | 2,216 | 484 | 533 | 499 |
| Net Income | (5,236) | (6,140) | (5,033) | (6,149) |
| Total Assets | 12,331 | 13,992 | 19,305 | 17,530 |
| Total Debt | 0 | 0 | 0 | 0 |
Kringle Pharma Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Kringle Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Kringle Pharma Comparisons
Industry
Financing
Details
Kringle Pharma Competitors (20)
One of Kringle Pharma’s 20 competitors is Savara, a Formerly VC-backed company based in Yardley, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Savara | Formerly VC-backed | Yardley, PA | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Biocon | Formerly PE-Backed | Bengaluru, India | ||||
| Avalyn Pharma | Formerly VC-backed | Boston, MA | ||||
| Coherus Oncology | Formerly VC-backed | Redwood City, CA |
Kringle Pharma Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Kringle Pharma Patents
Kringle Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024096038-A1 | Method for producing active hgf | Inactive | 01-Nov-2022 | ||
| EP-4585225-A1 | Spinal cord injury therapeutic targeting from acute phase to subacute phase | Pending | 08-Sep-2022 | ||
| EP-4585225-A4 | Spinal cord injury therapeutic targeting from acute phase to subacute phase | Pending | 08-Sep-2022 | ||
| US-20250381247-A1 | Spinal cord injury therapeutic targeting from acute phase to subacute phase | Pending | 08-Sep-2022 | ||
| WO-2024053721-A1 | Spinal cord injury therapeutic targeting from acute phase to subacute phase | Inactive | 08-Sep-2022 | A61K38/1833 |
Kringle Pharma Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Kringle Pharma Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Kringle Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Kringle Pharma FAQs
-
When was Kringle Pharma founded?
Kringle Pharma was founded in 2001.
-
Where is Kringle Pharma headquartered?
Kringle Pharma is headquartered in Osaka, Japan.
-
What is the size of Kringle Pharma?
Kringle Pharma has 19 total employees.
-
What industry is Kringle Pharma in?
Kringle Pharma’s primary industry is Drug Discovery.
-
Is Kringle Pharma a private or public company?
Kringle Pharma is a Public company.
-
What is Kringle Pharma’s stock symbol?
The ticker symbol for Kringle Pharma is 4884.
-
What is the current stock price of Kringle Pharma?
As of 13-Nov-2026 the stock price of Kringle Pharma is $3.48.
-
What is the current market cap of Kringle Pharma?
The current market capitalization of Kringle Pharma is $28.1M.
-
What is Kringle Pharma’s current revenue?
The trailing twelve month revenue for Kringle Pharma is $2.22M.
-
Who are Kringle Pharma’s competitors?
Savara, Bristol-Myers Squibb, Biocon, Avalyn Pharma, and Coherus Oncology are some of the 20 competitors of Kringle Pharma.
-
What is Kringle Pharma’s annual earnings per share (EPS)?
Kringle Pharma’s EPS for 12 months was -$0.71.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
